Insights

Precision Medicine Focus Goldfinch Bio is a pioneer in precision medicine for kidney diseases, offering unique therapeutic options targeting the underlying molecular causes. This focus on personalized treatment presents a strong sales opportunity for engaging with healthcare providers looking for innovative solutions.

Recent Strategic Partnerships Recent partnerships with companies like Karuna Therapeutics and investments from firms like Eventide Asset Management showcase Goldfinch Bio's industry recognition and growth potential. Leveraging these collaborations can open doors to new sales channels and market expansion opportunities.

Highly Experienced Leadership Team With key hires like Dr. Edwin Tucker as Chief Medical Officer and Dr. Jeff W. Jacobs as Chief Scientific Officer, Goldfinch Bio boasts a seasoned leadership team that brings expertise and credibility to the table. Utilizing the reputation and network of these leaders can enhance credibility during sales pitches and negotiations.

Innovative Product Pipeline Goldfinch Bio's robust pipeline of precision medicine product candidates targeting kidney diseases with significant unmet needs presents a compelling value proposition for potential buyers. Highlighting the innovative treatments in the pipeline can attract interest from healthcare institutions and pharmaceutical companies seeking breakthrough therapies.

Market Positioning and Competitive Landscape Goldfinch Bio's positioning in the biotechnology research industry alongside similar companies like Aligos Therapeutics and Carisma Therapeutics provides valuable insight into the competitive landscape. Understanding the market dynamics and differentiation factors can help sales teams tailor their approach to showcase the company's unique offerings and competitive advantages.

Goldfinch Bio Tech Stack

Goldfinch Bio uses 8 technology products and services including Google Analytics Enhanced eCommerce, Google Analytics, jQuery UI, and more. Explore Goldfinch Bio's tech stack below.

  • Google Analytics Enhanced eCommerce
    Analytics
  • Google Analytics
    Analytics
  • jQuery UI
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • RSS
    Miscellaneous
  • YouTube
    Video Players
  • Envoy
    Web And Application Servers

Media & News

Goldfinch Bio's Email Address Formats

Goldfinch Bio uses at least 1 format(s):
Goldfinch Bio Email FormatsExamplePercentage
FLast@goldfinchbio.comJDoe@goldfinchbio.com
50%
FLast@goldfinchbio.comJDoe@goldfinchbio.com
50%

Frequently Asked Questions

Where is Goldfinch Bio's headquarters located?

Minus sign iconPlus sign icon
Goldfinch Bio's main headquarters is located at 215 First Street Suite 400 Cambridge, Massachusetts 02142 US. The company has employees across 1 continents, including North America.

What is Goldfinch Bio's phone number?

Minus sign iconPlus sign icon
You can contact Goldfinch Bio's main corporate office by phone at +1-617-337-4200. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Goldfinch Bio's official website and social media links?

Minus sign iconPlus sign icon
Goldfinch Bio's official website is goldfinchbio.com and has social profiles on LinkedIn.

How much revenue does Goldfinch Bio generate?

Minus sign iconPlus sign icon
As of December 2023, Goldfinch Bio's annual revenue reached $3.8M.

What is Goldfinch Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Goldfinch Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Goldfinch Bio have currently?

Minus sign iconPlus sign icon
As of December 2023, Goldfinch Bio has approximately 11 employees across 1 continents, including North America. Key team members include Vice President And Head, Regulatory Affairs And Quality Assurance: C. R.Vice President, Drug Discovery: M. L.Vice President: L. C. S.. Explore Goldfinch Bio's employee directory with LeadIQ.

What industry does Goldfinch Bio belong to?

Minus sign iconPlus sign icon
Goldfinch Bio operates in the Biotechnology Research industry.

What technology does Goldfinch Bio use?

Minus sign iconPlus sign icon
Goldfinch Bio's tech stack includes Google Analytics Enhanced eCommerceGoogle AnalyticsjQuery UIjQueryOpen GraphRSSYouTubeEnvoy.

What is Goldfinch Bio's email format?

Minus sign iconPlus sign icon
Goldfinch Bio's email format typically follows the pattern of . Find more Goldfinch Bio email formats with LeadIQ.

How much funding has Goldfinch Bio raised to date?

Minus sign iconPlus sign icon
As of December 2023, Goldfinch Bio has raised $100M in funding. The last funding round occurred on Jun 30, 2020 for $100M.

When was Goldfinch Bio founded?

Minus sign iconPlus sign icon
Goldfinch Bio was founded in 2016.
Goldfinch Bio

Goldfinch Bio

Biotechnology ResearchMassachusetts, United States11-50 Employees

With our sole focus on kidney diseases, we aspire to be the world’s leading precision medicine kidney company. There are few therapeutic options that target the underlying cause of disease. Our solution to address this growing need is applying precision medicine to pioneer the discovery, development and commercialization of kidney disease treatments. 

Historically, there has been a ‘one size fits all’ approach to treating kidney disease. This has been due to the lack of understanding of kidney disease at the molecular level.

Thanks to a growing understanding of kidney biology and genetics, including pioneering research by the founders of Goldfinch, the scientific community is starting to understand the heterogeneity inherent in kidney diseases. 

Our precision medicine product engine is the foundation of our approach. Our product engine allows us to discover and validate novel targets aimed at understanding the molecular and phenotypic heterogeneity in diverse patient populations to identify patient subsets most likely to respond to our treatment.

We have a robust pipeline of novel, precision medicine product candidates targeting kidney diseases with significant unmet medical need.

If embracing creativity and candor, thriving on challenges, and empowering your teammates to succeed excites and inspires you, join us as we champion hope and change the face of kidney disease.

Section iconCompany Overview

Headquarters
215 First Street Suite 400 Cambridge, Massachusetts 02142 US
Phone number
+1-617-337-4200
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $100M

    Goldfinch Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on Jun 30, 2020 in the amount of $100M.

  • $10M

    Goldfinch Bio's revenue is in the range of $10M

Section iconFunding & Financials

  • $100M

    Goldfinch Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on Jun 30, 2020 in the amount of $100M.

  • $10M

    Goldfinch Bio's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.